/
Other
PK/PD
6
Pipeline Programs↗
5
Active Trials↗
21
Companies Involved↗
PK/PD is an early-stage landscape with 6 programs across 21 companies. The most active players are OriCell Therapeutics Co., Ltd., iN Therapeutics Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 15
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
49
clinical trials
Completed39 · 80%
Unknown status4 · 8%
Recruiting3 · 6%
Not yet recruiting2 · 4%
Terminated1 · 2%
Clinical Trials
Trial Activity
49 trials
Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants
Recruiting·—·Phase 1·NCT07182656·70 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)